Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MI › CASS CITY › HILLS & DALES GENERAL HOSPITAL, INC.

HILLS & DALES GENERAL HOSPITAL, INC.

NPI: 1154367001 · CASS CITY, MI 48726 · Critical Access Hospital · NPI assigned 06/21/2006

$7.07M
Total Medicaid Paid
270,433
Total Claims
232,672
Beneficiaries
197
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialCASTLE, WILLIAM (CFO)
NPI Enumeration Date06/21/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 24,287 $618K
2019 36,832 $736K
2020 31,780 $806K
2021 25,403 $990K
2022 31,680 $1.06M
2023 53,572 $1.33M
2024 66,879 $1.53M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 9,162 6,216 $1.31M
99283 Emergency department visit for the evaluation and management, moderate severity 11,907 7,825 $1.30M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 2,876 2,181 $912K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 10,150 9,256 $504K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4,579 4,195 $282K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3,967 3,092 $272K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 7,385 2,381 $267K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1,885 1,737 $222K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 6,641 2,184 $142K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1,367 1,341 $131K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2,507 2,399 $130K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 2,203 2,092 $125K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 2,731 982 $116K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1,939 1,471 $105K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 918 846 $76K
96361 Intravenous infusion, hydration; each additional hour 1,805 1,563 $75K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 600 394 $74K
71046 Radiologic examination, chest; 2 views 1,738 1,636 $74K
87428 2,583 2,489 $68K
96375 Therapeutic injection; each additional sequential IV push 1,616 1,413 $61K
71045 Radiologic examination, chest; single view 1,209 1,121 $59K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 2,855 2,788 $54K
80061 Lipid panel 5,393 5,363 $47K
84443 Thyroid stimulating hormone (TSH) 5,645 5,570 $45K
T1015 Clinic visit/encounter, all-inclusive 1,277 1,155 $42K
80053 Comprehensive metabolic panel 10,970 10,029 $39K
77067 Screening mammography, bilateral, including computer-aided detection 682 681 $39K
74177 Computed tomography, abdomen and pelvis; with contrast material 177 167 $35K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 12,398 10,952 $30K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1,803 1,791 $25K
36415 Collection of venous blood by venipuncture 12,534 11,161 $19K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,384 2,326 $18K
62323 65 36 $17K
97161 260 256 $17K
97162 287 283 $17K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 128 128 $16K
83036 Hemoglobin; glycosylated (A1C) 3,023 2,989 $15K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,829 1,775 $14K
73630 432 405 $12K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 527 521 $10K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 522 516 $10K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2,505 2,260 $10K
84439 2,313 2,268 $9K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 3,052 2,717 $9K
20611 155 130 $8K
74176 Computed tomography, abdomen and pelvis; without contrast material 65 62 $8K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 219 214 $8K
77063 Screening digital breast tomosynthesis, bilateral 464 461 $7K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 54 51 $7K
73610 218 203 $7K
80048 Basic metabolic panel (calcium, ionized) 2,744 2,474 $7K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 1,490 1,378 $6K
87086 Culture, bacterial; quantitative colony count, urine 2,310 2,193 $6K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 368 351 $6K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring 16 16 $6K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 737 402 $6K
73130 154 145 $5K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 31 29 $5K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 15 14 $5K
94726 29 28 $5K
73221 32 29 $5K
87081 1,513 1,493 $4K
00170 Anesthesia for intraoral procedures, including biopsy 49 49 $4K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 53 53 $4K
84481 423 416 $4K
82728 448 441 $3K
83735 2,362 2,112 $3K
73030 84 81 $3K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 48 48 $3K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 74 74 $3K
73562 96 94 $3K
99215 Prolong outpt/office vis 28 27 $3K
83550 539 531 $3K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 40 39 $2K
82607 376 370 $2K
20553 58 51 $2K
76705 Ultrasound, abdominal, real time with image documentation; limited 38 38 $2K
83540 599 589 $2K
0012A 61 61 $2K
97530 Therapeutic activities, direct patient contact, each 15 minutes 68 54 $2K
73110 54 47 $2K
73560 49 41 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 831 722 $2K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 93 91 $2K
99406 255 242 $2K
74018 46 44 $2K
87186 455 423 $2K
72141 13 12 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination 109 58 $2K
87481 74 73 $1K
87807 193 188 $1K
86140 961 898 $1K
80074 68 68 $1K
J1030 Injection, methylprednisolone acetate, 40 mg 317 271 $1K
0011A 67 67 $1K
85610 818 608 $1K
81025 1,750 1,682 $1K
87631 227 224 $1K
82043 379 378 $1K
85027 429 411 $1K
81002 820 793 $1K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 58 58 $1K
81001 2,535 2,396 $1K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 27 27 $1K
0031A 36 36 $1K
01992 69 68 $1K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 66 61 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg 3,073 2,807 $1K
72100 18 18 $941.81
70450 Computed tomography, head or brain; without contrast material 12 12 $907.45
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 56 56 $828.36
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 44 44 $813.76
76830 Ultrasound, transvaginal 13 13 $785.03
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 15 14 $764.91
20610 15 12 $722.10
J1010 Injection, methylprednisolone acetate, 1 mg 210 199 $716.13
87070 189 181 $673.35
83690 1,313 1,182 $661.31
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 27 26 $650.66
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 37 37 $605.13
92567 67 64 $592.57
90686 36 36 $534.74
51798 89 81 $516.22
87077 149 122 $473.61
99000 188 184 $439.06
87806 32 32 $429.74
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 66 63 $407.05
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 28 27 $406.14
96127 140 140 $385.53
73564 14 13 $349.56
81003 744 728 $281.89
84484 1,051 866 $270.40
82746 39 39 $269.76
85652 227 223 $262.84
83655 38 38 $237.39
83880 16 15 $236.27
80076 80 77 $234.67
87480 16 16 $205.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,581 1,528 $196.20
87660 15 15 $188.39
85651 91 85 $167.13
87088 39 37 $122.90
J2360 Injection, orphenadrine citrate, up to 60 mg 20 19 $114.54
93000 12 12 $109.92
84550 52 52 $102.48
86038 14 14 $84.15
86430 26 26 $75.60
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 13 13 $75.36
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 25 24 $66.22
94010 41 40 $47.02
82570 12 12 $23.05
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,744 1,617 $6.75
J1200 Injection, diphenhydramine hcl, up to 50 mg 90 80 $1.81
J7030 Infusion, normal saline solution , 1000 cc 998 928 $0.00
1159F 12,295 11,079 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 628 593 $0.00
3077F 1,589 1,493 $0.00
3078F 9,132 8,391 $0.00
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 66 64 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 124 105 $0.00
1033F 538 490 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 129 127 $0.00
94729 28 27 $0.00
1032F 33 31 $0.00
3050F 80 74 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 12 12 $0.00
99401 14 14 $0.00
3074F 10,660 9,703 $0.00
3079F 3,995 3,787 $0.00
1036F 3,923 3,636 $0.00
3049F 259 214 $0.00
2000F 10,559 9,567 $0.00
2010F 12,257 11,001 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 1,022 988 $0.00
1220F 672 643 $0.00
3080F 1,125 1,080 $0.00
J7050 Infusion, normal saline solution, 250 cc 663 547 $0.00
J0690 Injection, cefazolin sodium, 500 mg 79 76 $0.00
3008F 222 199 $0.00
A9585 Injection, gadobutrol, 0.1 ml 111 109 $0.00
1034F 2,132 1,870 $0.00
1125F 2,434 2,279 $0.00
3017F 214 187 $0.00
J2704 Injection, propofol, 10 mg 1,267 1,241 $0.00
2001F 155 136 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 85 80 $0.00
J3490 Unclassified drugs 124 73 $0.00
3048F 235 208 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 724 697 $0.00
3075F 2,065 1,977 $0.00
97802 13 13 $0.00
84703 12 12 $0.00
83605 115 109 $0.00
94760 71 65 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 42 42 $0.00
3014F 14 13 $0.00
J1170 Injection, hydromorphone, up to 4 mg 15 14 $0.00